tradingkey.logo

Quoin Pharmaceuticals Announces Initial Positive Clinical Data For Qrx003 From Pediatric Peeling Skin Syndrome Study

ReutersMay 14, 2025 11:47 AM

- Quoin Pharmaceuticals Ltd 2EB0y.F:

  • QUOIN PHARMACEUTICALS ANNOUNCES INITIAL POSITIVE CLINICAL DATA FOR QRX003 FROM PEDIATRIC PEELING SKIN SYNDROME STUDY

  • QUOIN PHARMACEUTICALS LTD - CLEAR IMPROVEMENT IN PATIENT'S SKIN AFTER 12 WEEKS

  • QUOIN PHARMACEUTICALS LTD: QRX003 IS BEING WELL TOLERATED AND NO ADVERSE EVENTS HAVE BEEN REPORTED

Further company coverage: [2EB0y.F]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI